Health & Life Sciences
Helping companies confront multifaceted issues and drive innovation in patient care through strategic guidance and regulatory support.
Why It Matters
The Health & Life Sciences sector holds the power to not only treat diseases, but also improve the human condition on a fundamental level. Achieving this requires navigating a complex mix of scientific, economic, and ethical considerations. Advances in technology are redefining patient care and drug discovery, while personalized medicine is transforming therapeutic approaches, and the shift to value-based care is reshaping the industry. With the right strategy and precise execution, companies and organizations can lead the way in driving scientific breakthroughs, while ensuring their benefits reach all corners of society.
Our Expertise
Our Health & Life Sciences experts offer unparalleled experience across the full spectrum of the sector, from rare diseases and oncology to immunology, vaccines, and non-communicable diseases. Our team works with small and mid-stage biotech firms, large multinational biopharma companies, diagnostics, medical technology, genomics, and healthcare delivery systems. We provide comprehensive solutions for navigating financial, political, reputational, and social challenges, supported by relationships with global decision-makers and a deep bench of clinical experts. Our goal is to help clients advance their missions and meet their objectives in a rapidly evolving landscape.
Sub Sectors
Pharmaceuticals · Biotech · Rare Diseases · Oncology · NCDs · Gene and Cell Therapy · Medical Devices · Public Health and Health Equity
Trends We Navigate
- Intellectual property challenges
- Healthcare nationalism and security concerns
- Cross-border data flows
- AI regulation in healthcare
- Evolution of the U.S. healthcare system
- Market access strategies
- Drug shortage mitigation
- M&A and business development
- Global supply chain optimization
- Sustainability and environmental regulations
- Geopolitical impacts on healthcare
- Advances in women’s health
- Developments in cell and gene therapy
- Impacts of the U.S. Inflation Reduction Act (IRA) on drug pricing
- Localization pressures
Featured Case Studies
Learn how we help companies and organizations in the Health & Life Sciences sector.
A leading global diagnostics company sought assistance in developing and executing a public affairs and stakeholder engagement strategy in Asia Pacific.
Learn more
One of the world’s leading healthcare providers was seeking to establish its international presence in East Asia & Pacific.
Learn more
A global health care company sought to navigate the complex regulatory and stakeholder landscapes in target markets to facilitate access and negotiate reimbursement agreements for its new product.
Learn more
A prominent U.S.-based cancer treatment and research center struggled with integrating employees from a newly acquired network of hospitals and outpatient centers.
Learn moreHealth & Life Sciences
senior team
Meet the people who are delivering impact, knowledge, and strategic insights in this area for companies and organizations around the globe.
